HAEMONETICS CORP Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Haemonetics Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Haemonetics Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 28, 2024 was 50.9M shares, a 0.34% increase year-over-year.
  • Haemonetics Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 50.7M shares, a 0.15% decline from 2022.
  • Haemonetics Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 50.8M shares, a 0.52% decline from 2021.
  • Haemonetics Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 51M shares, a 0.71% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 50.9M +171K +0.34% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-07
Q2 2024 50.9M +401K +0.79% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 50.7M -77K -0.15% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 50.8M +259K +0.51% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 50.7M -226K -0.44% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 50.5M -682K -1.33% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 50.8M -264K -0.52% Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 50.5M -585K -1.15% Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 51M -86K -0.17% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-02
Q2 2022 51.2M +285K +0.56% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 51M +359K +0.71% Jan 2, 2022 Apr 2, 2022 10-K 2024-05-20
Q4 2021 51.1M +305K +0.6% Oct 3, 2021 Jan 1, 2022 10-Q 2023-02-07
Q3 2021 51M +343K +0.68% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 50.9M +521K +1.03% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-10
Q1 2021 50.7M -4K -0.01% Dec 27, 2020 Apr 3, 2021 10-K 2023-05-22
Q4 2020 50.8M +159K +0.31% Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 50.7M -95K -0.19% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-09
Q2 2020 50.4M -592K -1.16% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 50.7M -841K -1.63% Dec 29, 2019 Mar 28, 2020 10-K 2022-05-25
Q4 2019 50.6M -771K -1.5% Sep 29, 2019 Dec 28, 2019 10-Q 2021-02-02
Q3 2019 50.8M -814K -1.58% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-04
Q2 2019 51M -1.11M -2.13% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q1 2019 51.5M -1.22M -2.32% Dec 30, 2018 Mar 30, 2019 10-K 2021-05-26
Q4 2018 51.4M -1.69M -3.18% Sep 30, 2018 Dec 29, 2018 10-Q 2020-02-04
Q3 2018 51.6M -1.01M -1.93% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-01
Q2 2018 52.1M -324K -0.62% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-07
Q1 2018 52.8M +1.23M +2.39% Dec 31, 2017 Mar 31, 2018 10-K 2020-05-20
Q4 2017 53.1M +1.38M +2.67% Oct 1, 2017 Dec 30, 2017 10-Q 2019-02-05
Q3 2017 52.6M +1.24M +2.42% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 52.4M +1.42M +2.79% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-07
Q1 2017 51.5M +614K +1.21% Jan 1, 2017 Apr 1, 2017 10-K 2019-05-22
Q4 2016 51.7M +967K +1.91% Oct 2, 2016 Dec 31, 2016 10-Q 2018-02-06
Q3 2016 51.4M +698K +1.38% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-07
Q2 2016 51M -339K -0.66% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-07
Q1 2016 50.9M -623K -1.21% Dec 27, 2015 Apr 2, 2016 10-K 2018-05-23
Q4 2015 50.7M -691K -1.34% Sep 27, 2015 Dec 26, 2015 10-Q 2017-02-06
Q3 2015 50.7M -711K -1.38% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-07
Q2 2015 51.4M -381K -0.74% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-01
Q1 2015 51.5M -78K -0.15% Dec 28, 2014 Mar 28, 2015 10-K 2017-05-24
Q4 2014 51.4M -298K -0.58% Sep 28, 2014 Dec 27, 2014 10-Q 2016-02-02
Q3 2014 51.4M -101K -0.2% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 51.7M +510K +1% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 51.6M +262K +0.51% Dec 29, 2013 Mar 29, 2014 10-K 2016-06-01
Q4 2013 51.7M +23K +0.04% Sep 29, 2013 Dec 28, 2013 10-Q 2015-02-05
Q3 2013 51.5M +72K +0.14% Jun 30, 2013 Sep 28, 2013 10-Q 2014-11-04
Q2 2013 51.2M +265K +0.52% Mar 31, 2013 Jun 29, 2013 10-Q 2014-07-31
Q1 2013 51.3M +622K +1.23% Dec 30, 2012 Mar 30, 2013 10-K 2015-05-22
Q4 2012 51.7M +1.55M +3.1% Sep 30, 2012 Dec 29, 2012 10-Q 2014-01-30
Q3 2012 51.4M +26M +102% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 51M +25.2M +98.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 50.7M +573K +1.14% Jan 1, 2012 Mar 31, 2012 10-K 2014-05-22
Q4 2011 50.2M +25.2M +101% Oct 2, 2011 Dec 31, 2011 10-Q 2013-02-01
Q3 2011 25.4M +732K +2.97% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-07
Q2 2011 25.7M +591K +2.35% Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-08
Q1 2011 50.2M Jan 2, 2011 Apr 2, 2011 10-K 2013-05-20
Q4 2010 25M Oct 3, 2010 Jan 1, 2011 10-Q 2012-02-06
Q3 2010 24.7M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-03
Q2 2010 25.1M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.